Exonics Therapeutics Acquired by Vertex, Expanding into New Disease Areas and Enhances Gene Editing Capabilities Portfolio News / admin June 6, 2019 Exonics Therapeutics Acquired by Vertex, Expanding into New Disease Areas and Enhances Gene Editing Capabilities Read More »
Constellation’s Interim Data for CPI-0610 in MANIFEST Clinical Trial Showed Signals of Clinical Activity in Myelofibrosis Patients Portfolio News / admin June 3, 2019 Constellation’s Interim Data for CPI-0610 in MANIFEST Clinical Trial Showed Signals of Clinical Activity in Myelofibrosis Patients Read More »
FLX Bio Announces Name Change to RAPT Therapeutics Portfolio News / admin May 24, 2019 FLX Bio Announces Name Change to RAPT Therapeutics Read More »
Peloton Therapeutics Acquired by Merck, Bolstering Oncology Pipeline Portfolio News / admin May 21, 2019 Peloton Therapeutics Acquired by Merck, Bolstering Oncology Pipeline Read More »
ORIC Pharmaceuticals Announces Initiation of Phase 1b Study with ORIC-101 in Patients with Cancer Portfolio News / admin May 13, 2019 ORIC Pharmaceuticals Announces Initiation of Phase 1b Study with ORIC-101 in Patients with Cancer Read More »
Arcus Biosciences Appoints William Grossman, M.D., Ph.D., Chief Medical Officer Portfolio News / admin May 2, 2019 Arcus Biosciences Appoints William Grossman, M.D., Ph.D., Chief Medical Officer Read More »
Gritstone Oncology Announces Pricing of $74.8 Million Public Offering of Common Stock Portfolio News / admin April 24, 2019 Gritstone Oncology Announces Pricing of $74.8 Million Public Offering of Common Stock Read More »
Gritstone Oncology Announces Clinical Acceleration of “Off-The-Shelf” Personalized Neoantigen Immunotherapy Program (SLATE) Following FDA Feedback Portfolio News / admin April 22, 2019 Gritstone Oncology Announces Clinical Acceleration of “Off-The-Shelf” Personalized Neoantigen Immunotherapy Program (SLATE) Following FDA Feedback Read More »
Gritstone Oncology Announces Proposed Public Offering of Common Stock Portfolio News / admin April 22, 2019 Gritstone Oncology Announces Proposed Public Offering of Common Stock Read More »
Surrozen Appoints Dr. Trudy Vanhove as Chief Medical Officer Portfolio News / admin April 11, 2019 Surrozen Appoints Dr. Trudy Vanhove as Chief Medical Officer Read More »